^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

Immunomodulator

Related drugs:
2d
New P2 trial
2d
Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT (clinicaltrials.gov)
P1, N=24, Recruiting, Stanford University | Not yet recruiting --> Recruiting
Enrollment open
|
HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1) • HLA-B (Major Histocompatibility Complex, Class I, B) • HLA-C (Major Histocompatibility Complex, Class I, C)
|
Jakafi (ruxolitinib) • Orca-T
2d
A multipronged Tα1 reset of CD8+ T cell cytotoxicity against breast cancer. (PubMed, Hum Immunol)
Complementary transcriptomic analysis using a compact four-gene Tα1 Response Index (Tα1-RI: TLR9, TLR2, IRF1, NLRC5) in TCGA-BRCA (n = 1,112) confirmed positive correlations with antigen presentation and cytotoxic programs and enrichment in CD8-like T cells in single-cell datasets. Collectively, these findings demonstrate that Tα1 enhances CD8+ T cell cytotoxicity while alleviating exhaustion, supporting its potential as an adjunct immunomodulator for improving immune surveillance in breast cancer.
Journal • BRCA Biomarker • PD(L)-1 Biomarker • IO biomarker
|
CD8 (cluster of differentiation 8) • PD-1 (Programmed cell death 1) • LAG3 (Lymphocyte Activating 3) • BRCA (Breast cancer early onset) • HAVCR2 (Hepatitis A Virus Cellular Receptor 2) • TLR9 (Toll Like Receptor 9) • GZMB (Granzyme B) • IRF1 (Interferon Regulatory Factor 1) • NLRC5 (NLR Family CARD Domain Containing 5) • TLR2 (Toll Like Receptor 2)
|
Zadaxin (thymalfasin)
3d
New trial
|
minocycline
3d
A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Efficacy and Safety of Voriconazole Ear Drops in the Treatment of Otomycosis (ChiCTR2500115712)
P=N/A, N=108, Completed, Third Xiangya Hospital of Central South University; Third Xiangya Hospital of Central South University
New trial
3d
Efficacy and Safety of Minocycline in the Treatment of Intracerebral Hemorrhage: a multicenter, randomized, open-label, blinded endpoint clinical study (ChiCTR2500114607)
P=N/A, N=1248, Not yet recruiting, The First Hospital of Jilin University; The First Hospital of Jilin University
New trial
|
minocycline
3d
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Bifidobacterium Tetravaccine Live Tablets in the Treatment of Patients with Cholestatic Liver Disease (ChiCTR2500112906)
P=N/A, N=198, Not yet recruiting, The Second Affiliated Hospital of the Army Medical University; The Second Affiliated Hospital of the Army Medical University
New trial
3d
Efficacy and Safety of Minocycline in Patients with Acute Spontaneous Intracerebral Hemorrhage (ChiCTR2600117240)
P4, N=1192, Not yet recruiting, Beijing Tiantan Hospital, Capital Medical University; Beijing Tiantan Hospital, Capital Medical University
New P4 trial
|
minocycline
3d
New P4 trial
|
minocycline
3d
Efficacy and Safety of Ursodeoxycholic Acid in Participants with Mild to Moderate Ulcerative Colitis: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial (ChiCTR2500113946)
P3, N=378, Not yet recruiting, The First Affiliated Hospital of Army Medical University; The First Affiliated Hospital of Army Medical University
New P3 trial
4d
Exploration and Preliminary Investigation of Wiled Tinospora crispa: A Medicinal Plant with Promising Anti-Inflammatory and Antioxidant Properties. (PubMed, Curr Issues Mol Biol)
Metabolomic characterization using UHPLC-ESI-QTOF-MS, supported by NMR, to confirm key compounds such as berberine, palmatine, chlorogenic acid, rutin, and borapetoside C. In vitro bioassays including: Antioxidant activity (e.g., radical-scavenging assay with EC50 determination)...Cultivation strategies that deliberately maintain or mimic beneficial stress conditions to preserve phytochemical richness. Broader geographical and genetic sampling to assess how generalizable the present chemotypic and bioactivity patterns are across the species.
Journal
|
GEN1 (GEN1 Holliday junction 5' flap endonuclease)
|
chlorogenic acid